SPONTANEOUS INTRAHEPATIC PORTOSYSTEMIC VENOUS SHUNT

This adverse event was reported 12 times

These drugs are most commonly taken by patients reporting SPONTANEOUS INTRAHEPATIC PORTOSYSTEMIC VENOUS SHUNT:

# Drug Count
0 MACITENTAN 7
1 SILDENAFIL 7
2 SILDENAFIL CITRATE 7
3 SILDENAFIL POWDER, 6
4 TACROLIMUS 6
5 TACROLIMUS EXTENDED-RELEASE CAPSULES 6
6 TACROLIMUS OINTMENT 0.1% 6
7 ATEZOLIZUMAB 1
8 BEVACIZUMAB 1
9 CERTOLIZUMAB PEGOL 1
See all common drugs associated with SPONTANEOUS INTRAHEPATIC PORTOSYSTEMIC VENOUS SHUNT

SPONTANEOUS INTRAHEPATIC PORTOSYSTEMIC VENOUS SHUNT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ILOPROST 1 0.0011
1 SILDENAFIL POWDER, 6 0.0002
2 MACITENTAN 7 0.0001
3 SILDENAFIL CITRATE 7 0.0001
4 TACROLIMUS OINTMENT 0.1% 6 0.0000
5 TACROLIMUS EXTENDED-RELEASE CAPSULES 6 0.0000
6 TACROLIMUS 6 0.0000
7 LENVATINIB 1 0.0000
8 ATEZOLIZUMAB 1 0.0000
9 OXALIPLATIN 1 0.0000
See all drugs enriched for association with SPONTANEOUS INTRAHEPATIC PORTOSYSTEMIC VENOUS SHUNT